Illumina has entered into a definitive agreement with Standard BioTools under which the company will acquire SomaLogic.

LOTTE will manufacture antibody drug substance for Ottimo Pharma’s product at LOTTE’s Syracuse Bio Campus in New York.

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.

Nicole Verdun, MD, super office director of the FDA’s Office of Therapeutic Products (OTP) and her deputy Rachael Anatol, PhD ...

AAVs play a key role in delivering gene therapies, and precise measurement of the empty/full capsid ratio—a critical quality ...

RNA-seq and spatial transcriptomics showed immune cell subsets that drive kidney and lung complications in systemic sclerosis ...

The AI unicorn's Perturb-seq atlas is publicly available and detects dose-dependent genetic effects to enhance predictive ...

FDA Commissioner Martin Makary, MD, shared his vision for a “New FDA” with biopharma leaders attending BIO in Boston.

Two biotech innovators launched products that solve challenges in gene therapy scale-up and learn from omics data from ...

The ability to make patient-specific products quickly fits with the needs of smaller, resource-limited developers.

When tested in a mouse model of breast cancer, the doxorubicin-loaded nanoparticles caused fewer side effects than free ...

For some trees, wasted bark is a potential treasure-trove of biopharmaceuticals—from anti-inflammatories to cancer-fighting ...